loading
전일 마감가:
$14.50
열려 있는:
$14.39
하루 거래량:
10,127
Relative Volume:
0.18
시가총액:
$25.63M
수익:
-
순이익/손실:
$-4.85M
주가수익비율:
-20.49
EPS:
-0.7012
순현금흐름:
$-3.95M
1주 성능:
-12.73%
1개월 성능:
-5.12%
6개월 성능:
+129.52%
1년 성능:
+92.68%
1일 변동 폭
Value
$14.01
$14.99
1주일 범위
Value
$14.07
$17.25
52주 변동 폭
Value
$5.40
$32.55

Cadrenal Therapeutics Inc Stock (CVKD) Company Profile

Name
명칭
Cadrenal Therapeutics Inc
Name
전화
904-300-0701
Name
주소
822 A1A NORTH, PONTE VEDRA
Name
직원
4
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CVKD's Discussions on Twitter

CVKD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
CVKD 14.17 25.63M 0 -4.85M -3.95M -0.7012
VRTX 446.95 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.11 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.63 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 250.00 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.98 24.49B 3.30B -501.07M 1.03B 11.54

Cadrenal Therapeutics Inc 주식(CVKD)의 최신 뉴스

pulisher
Nov 20, 2024

CVKD: Recent Financings Raise $9.8 Million… - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook - StockTitan

Nov 19, 2024
pulisher
Nov 18, 2024

(CVKD) Technical Data - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Cadrenal Therapeuti - GuruFocus.com

Nov 15, 2024
pulisher
Nov 12, 2024

Cadrenal's Tecarfarin Shows Promise for LVAD Patients in Key Medical Congress Data | CVKD Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS - PR Newswire

Nov 12, 2024
pulisher
Nov 11, 2024

Cadrenal shares gain; analyst highlights Buy rating and key LVAD trial advancements - Investing.com Canada

Nov 11, 2024
pulisher
Nov 09, 2024

Cadrenal Therapeutics Provides Third-Quarter Corporate Update - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Cadrenal Therapeutics Advances Tecarfarin Development - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

(CVKD) Long Term Investment Analysis - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 07, 2024

Cadrenal Therapeutics Raises $9.8M, Advances Unique Anticoagulant Drug Development | CVKD Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE - PR Newswire

Nov 07, 2024
pulisher
Nov 01, 2024

Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds - StockTitan

Nov 01, 2024
pulisher
Oct 31, 2024

Here's Why We're Watching Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation - Simply Wall St

Oct 31, 2024
pulisher
Oct 28, 2024

We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

(CVKD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 24, 2024

Cadrenal Therapeutics secures $5.1 million in share sale - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility - PR Newswire

Oct 24, 2024
pulisher
Oct 23, 2024

CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM - PR Newswire

Oct 23, 2024
pulisher
Oct 17, 2024

Short Interest in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Drops By 7.2% - MarketBeat

Oct 17, 2024
pulisher
Oct 15, 2024

Renaissance Technologies LLC Reduces Stock Position in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) - MarketBeat

Oct 15, 2024
pulisher
Oct 07, 2024

Long Term Trading Analysis for (CVKD) - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 03, 2024

Jacksonville stocks rise as market hits record highs - Jacksonville Daily Record

Oct 03, 2024
pulisher
Sep 30, 2024

Short Interest in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Rises By 22.8% - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Cadrenal Therapeutics Inc (CVKD-Q) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 26, 2024

Where are the Opportunities in (CVKD) - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 25, 2024

Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy - TipRanks

Sep 25, 2024
pulisher
Sep 23, 2024

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference - Kilgore News Herald

Sep 23, 2024
pulisher
Sep 19, 2024

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Forecasted to Earn Q3 2024 Earnings of ($2.18) Per Share - MarketBeat

Sep 19, 2024
pulisher
Sep 18, 2024

Applied Therapeutics (NASDAQ:APLT) Trading Down 4.1% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

WATCH LIVE: Fed Chair Jerome Powell speaks after a 50bp interest rate cut - Investing.com

Sep 18, 2024
pulisher
Sep 16, 2024

Cancer Biotech Nuvalent’s Stock Jumps on Positive Data - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

Cadrenal Therapeutics (CVKD) Stock Rallies In After-Market Trading Ahead Of Regulatory Meeting - Stocks Telegraph

Sep 16, 2024
pulisher
Sep 12, 2024

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Short Interest Update - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

Eli Lilly invests $1.8B to boost manufacturing footprint in Ireland - MSN

Sep 12, 2024
pulisher
Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024
pulisher
Sep 05, 2024

Cadrenal Therapeutics regains Nasdaq compliance - Investing.com India

Sep 05, 2024
pulisher
Aug 23, 2024

Cadrenal gears up for FDA talks on heart drug trial - Investing.com India

Aug 23, 2024
pulisher
Aug 22, 2024

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients - PR Newswire

Aug 22, 2024
pulisher
Aug 20, 2024

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients - PR Newswire

Aug 20, 2024
pulisher
Aug 19, 2024

Upcoming Stock Splits This Week (August 19 to August 23) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News

Aug 19, 2024
pulisher
Aug 19, 2024

Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested - MSN

Aug 19, 2024
pulisher
Aug 16, 2024

Cadrenal Therapeutics to Implement 1-for-15 Reverse Stock Split - Marketscreener.com

Aug 16, 2024
pulisher
Aug 16, 2024

Cadrenal announces 1-for-15 reverse stock split By Investing.com - Investing.com Australia

Aug 16, 2024
pulisher
Aug 16, 2024

Cadrenal announces 1-for-15 reverse stock split - Investing.com

Aug 16, 2024
pulisher
Aug 15, 2024

Cadrenal Therapeutics Inc: Analyzing CVKD Stock Trends - The InvestChronicle

Aug 15, 2024
pulisher
Aug 14, 2024

CVKDCadrenal Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Aug 14, 2024
pulisher
Aug 14, 2024

Cadrenal Therapeutics to Present at Upcoming Investor Conferences - Longview News-Journal

Aug 14, 2024
pulisher
Aug 12, 2024

Cadrenal Therapeutics, Inc. (CVKD): A New Penny Stock to Buy Now - Yahoo Finance

Aug 12, 2024
pulisher
Aug 12, 2024

Q3 2024 Earnings Estimate for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Issued By HC Wainwright - Defense World

Aug 12, 2024

Cadrenal Therapeutics Inc (CVKD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):